← Open Payments lookup

CONSTANCE ANTON: Open Payments

NPI 1679656904 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$613 in 28 payments from 13 companies in 2025. Trend: 2023 $128 · 2024 $305 · 2025 $613

Food & beverage: $613
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$145
Otsuka America Pharmaceutical, Inc.4$75
Janssen Pharmaceuticals, Inc3$65
Lundbeck LLC3$50
ABBVIE INC.2$48
E.R. Squibb & Sons, L.L.C.2$42
Takeda Pharmaceuticals U.S.A., Inc.2$36
Vanda Pharmaceuticals Inc.1$36
Neurocrine BioSciences, Inc.1$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26

Products named: UZEDY, REXULTI, VRAYLAR, ABILIFY MAINTENA, COBENFY, AUSTEDO XR, TRINTELLIX, INVEGA SUSTENNA.

Industry payments across MD — which companies pay providers there.